Cargando…

The Role of Tinzaparin in Oncology

Current guidelines recommend low-molecular-weight heparin treatment in patients with cancer with established venous thromboembolism (VTE). The aim of this article was to study the pharmacological properties and effectiveness of tinzaparin in patients with cancer as well as its potential anticancer p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dimakakos, Evangelos P., Vathiotis, Ioannis, Syrigos, Konstantinos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714870/ https://www.ncbi.nlm.nih.gov/pubmed/29088922 http://dx.doi.org/10.1177/1076029617729215

Ejemplares similares

Tinzaparin Safety in Patients With Cancer and Renal Impairment: A Systematic Review
por: Vathiotis, I. A., et al.
Publicado: (2021)

H1N1-Induced Venous Thromboembolic Events? Results of a Single-Institution Case Series
por: Dimakakos, Evangelos, et al.
Publicado: (2016)

Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma
por: Vathiotis, Ioannis, et al.
Publicado: (2018)

Extended-Duration Treatment of Superficial Vein Thrombosis of the Lower Limbs with Tinzaparin
por: Nikolakopoulos, Konstantinos M., et al.
Publicado: (2018)

HER2 Aberrations in Non-Small Cell Lung Cancer: From Pathophysiology to Targeted Therapy
por: Vathiotis, Ioannis A., et al.
Publicado: (2021)

Evolving Treatment Landscape of HER2-mutant Non-Small Cell Lung Cancer: Trastuzumab Deruxtecan and Beyond
por: Vathiotis, Ioannis A., et al.
Publicado: (2023)

High versus Standard Intensity of Thromboprophylaxis in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
por: Kollias, Anastasios, et al.
Publicado: (2021)

Thromboprophylaxis in COVID-19: Early initiation might be as important as optimal dosing
por: Kollias, Anastasios, et al.
Publicado: (2021)

Emerging therapies in thymic epithelial tumors (Review)
por: Dapergola, Athina, et al.
Publicado: (2023)

Tinzaparin vs. Nadroparin Safety and Efficacy in Neurosurgery
por: Wilhelmy, Florian, et al.
Publicado: (2021)

Vaccine-Related Autoimmune Hepatitis: Emerging Association with SARS-CoV-2 Vaccination or Coincidence?
por: Trontzas, Ioannis P., et al.
Publicado: (2022)

Tumor Dormancy: Implications for Invasion and Metastasis
por: Gomatou, Georgia, et al.
Publicado: (2021)

Programmed Death-Ligand 1 as a Regulator of Tumor Progression and Metastasis
por: Vathiotis, Ioannis A., et al.
Publicado: (2021)

Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer
por: Sarantis, Panagiotis, et al.
Publicado: (2021)

Tinzaparin—a review of its molecular profile, pharmacology, special properties, and clinical uses
por: Amerali, Marina, et al.
Publicado: (2022)

Takotsubo Cardiomyopathy in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Summary of Included Cases
por: Trontzas, Ioannis P., et al.
Publicado: (2023)

Heparin/tinzaparin-sodium: Lack of efficacy: 3 case reports
Publicado: (2020)

Tinzaparin-sodium: Bleeding and deep venous thrombosis: case report
Publicado: (2022)

Weight-adjusted dosing of tinzaparin for thromboprophylaxis in obese medical patients
por: Pfrepper, Christian, et al.
Publicado: (2023)

CD24: A Novel Target for Cancer Immunotherapy
por: Panagiotou, Emmanouil, et al.
Publicado: (2022)

Programmed Cell Death Protein 1 Axis Inhibition in Viral Infections: Clinical Data and Therapeutic Opportunities
por: Tsiakos, Konstantinos, et al.
Publicado: (2022)

Tinzaparin and other low-molecular-weight heparins: what is the evidence for differential dependence on renal clearance?
por: Johansen, Kristian B, et al.
Publicado: (2013)

Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis
por: Mahmood, Dana, et al.
Publicado: (2010)

Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications
por: Helfer, Hélène, et al.
Publicado: (2019)

Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study
por: Akinosoglou, Karolina, et al.
Publicado: (2022)

New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge?
por: Rapti, Vasiliki, et al.
Publicado: (2022)

Tinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer: A Systematic Review and Meta-Analysis
por: Martínez-Zapata, M. José, et al.
Publicado: (2017)

Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials
por: Kyriakoulis, Konstantinos G., et al.
Publicado: (2022)

The Impact of Thromboprophylaxis on the Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer and Tinzaparin (PaCT) Study
por: Karamouzis, Michalis V., et al.
Publicado: (2021)

Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence
por: Christopoulou, Athina, et al.
Publicado: (2022)

Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
por: Trujillo‐Santos, Javier, et al.
Publicado: (2022)

Single-Bolus Tinzaparin Anticoagulation in Extended Hemodialysis Session: A Feasibility Study
por: Harvey, Benoît, et al.
Publicado: (2023)

Cancer-Associated Thrombosis: Not All Low-Molecular-Weight Heparins Are the Same, Focus on Tinzaparin, A Narrative Review
por: Fioretti, Agnese Maria, et al.
Publicado: (2022)

Spontaneous gall bladder haemorrhage in a renal dialysis patient following haemodialysis with tinzaparin
por: Borman, Natalie, et al.
Publicado: (2010)

Malignant Superior Vena Cava Syndrome: State of the Art
por: Patriarcheas, Vasileios, et al.
Publicado: (2022)

Significant Increase in Blood Pressure Following BNT162b2 mRNA COVID-19 Vaccination among Healthcare Workers: A Rare Event
por: Syrigos, Nikolaos, et al.
Publicado: (2022)

The Role of B Cells in Head and Neck Cancer
por: Gavrielatou, Niki, et al.
Publicado: (2021)

Tinzaparin Provides Lower Lipid Profiles in Maintenance Hemodialysis Patients: A Cross-Sectional Observational Study
por: Tsai, Ming-Hsien, et al.
Publicado: (2014)

TILE pilot trial study protocol: Tinzaparin Lead-in to Prevent the Post-Thrombotic syndrome study protocol
por: Makedonov, Ilia, et al.
Publicado: (2023)

Recent Advances in Molecular Diagnosis of Thyroid Cancer
por: Legakis, Ioannis, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_j2tgcvdov5kfg1ro7678bgu3o6